Success Metrics

Clinical Success Rate

100.0%

Based on 7 completed trials

Completion Rate

100%(7/7)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

14%

Ph phase_1

14%

Ph phase_2

71%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

1(14.3%)

Phase 2Efficacy & side effects

5(71.4%)

N/ANon-phased studies

1(14.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(7)

Detailed Status

Completed7

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (14.3%)

Phase 25 (71.4%)

N/A1 (14.3%)

Trials by Status

completed7100%

Recent Activity

0 active trials

Showing 5 of 7

completednot_applicable

Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells

NCT01092026

completedphase_2

Clinical Trials (7)

Showing 7 of 7 trials

NCT01092026Not Applicable

Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells

Completed

NCT01966510Phase 2

Cord Blood Transplantation in Patients With Advanced Lymphoid Malignancies

Completed

NCT01343953Phase 2

Cord Blood Transplantation in Severe Aplastic Anemia

Completed

NCT00029380Phase 2

Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia

Completed

NCT00514579Phase 2

Adult Double Cord Blood Transplant Study

Completed

NCT00797758Phase 2

Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia

Completed

NCT00270881Phase 1

Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies

Completed

All 7 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 7